Genomic Analysis

Predict the risk of breast cancer with a simple saliva test [VIDÉO] | Health | News | The sun | 7/12/2020

… in Oncogenetics at the Faculty of Medicine of Laval University and researcher at the Research Center of the CHU de Québec, explains that several hundred researchers around the world, from DNA samples, conducted a genomic analysis on 94,000 women who had breast cancer and on a control group of 75,000 women. “Thanks to sophisticated statistical analyzes, we were able to develop a breast cancer risk score that includes 313 genetic …

pseudomallei Burkholderia sp MSMB175 was negative for all B ps | 7/12/2020

… bands (Figure 1). The O-antigen biosynthesis gene cluster for this strain was subsequently sequenced and found to be type B2 (GenBank: JQ783347), with a nucleotide identity of 88% compared to B. pseudomallei MSHR840. Genomic analysis Genomic comparison has check details shown that a homolog of wbiE gene in B. oklahomensis E0147 (BoklE_010100014785) had one and five single nucleotide polymorphisms (SNPs) at the forward and reverse primer binding sites …

Follow Genomic Analysis:    

Analysis of conserved miRNAs in cynomolgus macaque genome using small RNA sequencing and homology searching | 7/10/2020

… evaluation ( Theriault et al., 1999 ; Carter, 2011 ; Grigsby, 2016 ; Yang et al., 2014 ; Willard & Shively, 2012 ), thus prompting the sequencing of its genome ( Ebeling et al., 2011 ; Yan et al., 2011 ). Based on comparative genomic analysis , cynomolgus macaques share 99.2% and 92.8% genomic identity with rhesus macaques and humans, respectively ( Veeranagouda et al., 2015 ). Furthermore, recent animal study indicates a strong correlation between increasing metazoan morphological disparity and miRNA repertoires …

Agreement to File a Friendly Takeover Bid Initiated by ONCODNA on INTEGRAGEN to Acquire All Outstanding Shares at a Price of 2.20€ Per Share | Business Wire | 7/9/2020

… has developed a portfolio of software for genomic data interpretation that are distributed on a SaaS model and already commercialized in Europe and the USA. IntegraGen’s activities are particularly complementary to OncoDNA’s offer. Comprehensive genomic analysis of cancer cells has become increasingly relevant as a part of the cancer treatment decision making process, especially with the surge in targeted therapies and immunotherapies. The ability to detect and determine genomic differences …

IDEAL, the Infectious Diseases of East African Livestock project open access database and biobank | Business Wire | 7/9/2020

… EDTA tubes in a 1:1 ratio with ‘magic buffer’ (which acted as an anti-coagulant, anti-fungus, anti-bacterial and preservative; Biogen Diagnostica, Villaviciosa De Odon, Spain) at the recruitment visit in readiness for genomic analysis . DNA was extracted from these samples using the Nucleon Genomic DNA extraction kit (TepnelnLife Sciences, Manchester, UK). The Illumina ® BovineSNP50 v. 1 BeadChip (Illumina Inc., San Diego, CA, USA) used to genotype the cattle …

Global X: How the genomics field is fighting COVID-19 | 7/9/2020

… is entirely novel (new to humans), and 2) since it latches on to cells via the ACE2 receptor, likely came from the wild, spreading to humans either through bats or pangolins (zoonotic). 28 Computational genomic analysis processed by artificial intelligence gives us further detail, assessing with high probability that the virus originated from bats. 29 Subsequent genomes give us an idea of the virus’ transmission path. SARS-CoV-2 mutates …

Takeda teams up with Twist Bioscience to boost biologics R&D | FierceBiotech | 7/9/2020

… at the start of 2020 announced a handful of new collaborations amid a $140 million raise from an underwritten public offering. The company is working on delivering a new solution focused on data and genomic analysis with the help of Sophia Genetics as well as the development of target enrichment tools and library preparation kits through collaborations with GenapSys and Miroculus. The $140 million brought in by Twist came from …

Sleeping with the Enemy - Achieving Collaborative Success : The more others take the more we gain, and the less the cost the more the value: key questions to ask | 7/7/2020

Sharing good principles of collaborative working to help people solve complex problems. Friday, 29 August 2014 The more others take the more we gain, and the less the cost the more the value: key questions to ask Novartis , the global drug company, made a genomic analysis of Type 2 Diabetes (the fruits of its collaboration with several academic institutions) freely available on the Internet. A great number of scientists and …

Coronavirus research updates: Autopsies link immune response to death from COVID-19 | The Guardian | 7/7/2020

… 2020). How countries are using genomics to help avoid a second coronavirus wave The team tracked the number of times the virus reached the United Kingdom and began to spread inside the country’s borders. Genomic analysis found that there were 1,356 such introductions, although the researchers say that this number is preliminary and probably an underestimate. Travellers from Spain accounted for roughly one-third of those introductions, and travellers from …

Decoding the evolutionary response to prostate cancer therapy by plasma genome sequencing | 7/6/2020

… bone biopsies are most frequently needed for pathological and molecular characterization, but these are uncomfortable and difficult to perform procedures that often result in minute amounts of tumor tissue that is not suitable for genomic analysis . As a result, mPC presents a unique opportunity for liquid biopsy genomics to investigate heterogeneity and clonal evolution over time in the context of therapy. Results PEGASUS method While prospective studies typically use Streck …

Genomic analysis of the diversity, antimicrobial resistance and virulence potential of Campylobacter jejuni and Campylobacter coli strains from a private health care center in Central Chile | 7/3/2020

Advanced Search New Results Genomic analysis of the diversity, antimicrobial resistance and virulence potential of Campylobacter jejuni and Campylobacter coli strains from a private health care center in Central Chile View ORCID Profile Veronica Bravo , View ORCID Profile Assaf Katz , View ORCID Profile Lorena Porte , View ORCID Profile Thomas Weitzel , Carmen Varela , View ORCID Profile Narjol Gonzalez-Escalona , View ORCID Profile Carlos J Blondel doi: https://doi.org/10.1101/2020.07.03.182048 Veronica Bravo …

Whole-genome, transcriptome, and methylome analyses provide insights into the evolution of platycoside biosynthesis in Platycodon grandiflorus , a medicinal plant | 7/1/2020

… In this study, we sequenced the genome of P. grandiflorus and investigated the genes involved in platycoside biosynthesis. The draft genome of P. grandiflorus is 680.1 Mb long and contains 40,017 protein-coding genes. Genomic analysis revealed that the CYP716 family genes play a major role in platycoside oxidation. The CYP716 gene family of P. grandiflorus was much larger than that of other Asterid species. Orthologous gene annotation also revealed …

Agriculture Minister visits LIC to check out its genomic analysis technology | 6/30/2020

Bob Edlin Agriculture Minister Damien O’Connor today visited LIC to view its herd testing facilities and new multi-million genomic analysis technology which will ultimately put the dairy industry in a stronger position as it prepares for its role in New Zealand’s economic recovery after COVID-19. The Minister toured LIC’s Riverlea Road herd testing and GeneMark facility in Hamilton with LIC’s Chief Executive, Wayne McNee, Chief Scientist Richard Spelman …

DermTech Announces Inclusion in the Russell 2000 Index | Business & Finance | manchestertimes.com | Business Wire | 6/30/2020

… skin genomics platform. DermTech’s mission is to transform the practice of dermatology through more accurate diagnosis and treatment, and the elimination of unnecessary surgery, leading to improved patient care and lower costs. DermTech provides genomic analysis of skin samples collected non-invasively using an adhesive patch rather than a scalpel. DermTech markets and develops products that facilitate the early detection of skin cancers, and is developing products that assess inflammatory …

The smart Trick of bioinformatics assignment help That No One is Discussing | 6/29/2020

… been cited at the end of the presentation These hypothetical instances brought up through the ELSI Project illustrate there are implications of genetic details availability into regions of bioethics, and also legislation.The implication for genomic analysis is the fact that bioinformatics resources, indeed the sector itself, happens to be remodeled via a advancement in computational electric power. The next slide from Collin’s presentation underscores this, but says a little something …

Considerations To Know About bioinformatics assignment help | 6/29/2020

… establish and optimise de-novo genome assemblies for a variety of species3 Create in-silico gene prediction models and practical annotation4 Properly apply graph principle and its software in Organic details Evaluation.The implication for genomic analysis is usually that bioinformatics equipment, certainly the field by itself, happens to be remodeled via a growth in computational ability. The next slide from Collin’s presentation underscores this, but says a thing surprising about …

Beyond the Chicken or the Egg | GenomeWeb | 6/29/2020

A genomic analysis indicates chickens were domesticated from red jungle fowl more than 9,000 years ago, Science reports …

Cell Therapy Market To Reach USD 8.75 Billion by 2027 | Reports And Data | PR Newswire | 6/29/2020

… in oncology will experience higher growth, owing to a large number of pipeline projects for the treatment of tumors or cancer. The inception of effective guidelines for cell therapy manufacturing, the development of advanced genomic analysis techniques, a vast number of research by cancer societies, and proven effectiveness of transplants are some of the primary growth stimulants for the market. Certain pharmacological and manufacturing issues and regulatory hurdles are restricting …

The Hyperion-insideHPC Interviews: Rich Brueckner Talks with Jack Collins about the Emergence of ‘HPC Everywhere’ and Its Impact on Science | 6/26/2020

… for Cancer Research. Dr. Collins’ research focuses on biomedical computing applications pertaining to cancer. His research group develops and applies high-performance algorithms to solve data-intensive computational biology problems in the areas of genomic analysis , pattern recognition in proteomics and imaging, molecular modeling, and systems biology. He received his BA degree in mathematics from Park College with minors in physics, chemistry, and economics. His Ph.D. is in physical chemistry …

Genomic Analysis of the SUMO-Conjugating Enzyme and Genes under Abiotic Stress in Potato (Solanum tuberosum L.) | 6/26/2020

SUMO-conjugating enzymes (SCE) and SUMO (Small Ubiquitin-Like Modifiers) genes are important components of SUMOylation. SCE has a crucial role during the SUMOylation process which acts as a catalyst to transfer SUMO to the target protein. Comprehensive studies on SCE and SUMO have been performed in some plants, but studies on these genes remain limited in potato. This study is aimed at exploring the role of StSCE and StSUMO …

IMIX: A multivariate mixture model approach to integrative analysis of multiple types of omics data | 6/24/2020

Motivation: Integrative genomic analysis is a powerful tool to study the biological mechanisms underlying a complex disease or trait across multiplatform high-dimensional data, such as DNA methylation, copy number variation (CNV), and gene expression. It is common to perform large-scale genome-wide association analysis of an outcome for each data type separately and combine the results ad hoc, leading to loss of statistical power and uncontrolled overall false …

ArcherDx Abandons $100M IPO and is Set to be Acquired by Invitae | 6/23/2020

… to acquire ArcherDx and the move signals a major shift in the precision oncology landscape. The transaction, should all the milestones be met, is valued at $1.4 billion. Boulder, CO-based ArcherDx is a genomic analysis company and was founded in 2013 and has between 101 and 250 employees according to an entry in crunchbase.com . The combined company will Integrate germline testing, tumor profiling and liquid biopsy technologies and services …

Oncotarget: Mutation profile of primary subungual melanomas in Caucasians | 6/23/2020

… gmail.com To learn more about Oncotarget, please visit https://www.oncotarget.com Volume 11 Issue 25 of @Oncotarget reported that this study aimed to define the mutation profile of SUM in Caucasians. Next-generation sequencing-based genomic analysis was used to identify frequently mutated loci in 50 cancer-related genes in 31 SUM primary tumors. The most abundant mutations in SUM were found in KIT - in 13% of cases and NRAS - also …

Unique genomic features of fatal coronaviruses | National Institutes of Health | 6/23/2020

A genomic analysis may help explain why some coronaviruses, like SARS-CoV-2, can be deadly, while others cause only mild illness. The findings could help guide the development of treatments for COVID-19 and identify coronaviruses that might pose a threat to humans in the future. SARS-CoV-2, the virus that causes COVID-19, isolated from a patient in the U.S. The spikes on the outer edge of …

Whole-genome sequence analyses of Glaesserella parasuis isolates reveals extensive genomic variation and diverse antibiotic resistance determinants | 6/22/2020

… ksgA, and bcr ) in G. parasuis were identified . Resistance determinants ( sul2, aph(3”)-Ib, norA, bacA , ksgA, and bcr ) were widespread across isolates, regardless of serovar, isolation source, or geographical location. Conclusions Our comparative genomic analysis of worldwide G. parasuis isolates provides valuable insight into the emergence and transmission of G. parasuis in the swine industry. The result suggests the importance of transposon-related and/or plasmid-related gene variations …

NIH

Unique genomic features of fatal coronaviruses | National Institutes of Health | 6/23/2020

A genomic analysis may help explain why some coronaviruses, like SARS-CoV-2, can be deadly, while others cause only mild illness. The findings could help guide the development of treatments for COVID-19 and … by Drs. Noam Auslander, Ayal Gussow, and Eugene Konnin of NIH’s National Library of Medicine (NLM) set out to identify features of the viruses’ genomes that can make them deadly. In addition to NLM, the …

Medicare

Opinion: A national registry could help defeat sepsis, a big contributor to Covid-19 deaths | STAT | 6/9/2020

… in a matter of weeks to months, but some experience permanent deficits. advertisement Additionally, based on a recent analysis of Medicare beneficiaries who survived sepsis, older survivors of Covid-19-related sepsis will face a … 75% in 1975. We now have the capability to perform genomic analysis on cancer cells and determine the most effective treatment individualized to the patient, minimizing unnecessary side effects. A sepsis registry will provide the …

Genomics

Key Players in The $852 Million Genomics Market At Investing in New Product Launches | PR Newswire | 4/13/2020

LONDON , April 13, Companies in the global genomics are investing in new product launches to increase their revenue and expand their consumer base, and also for gaining a competitive edge over their rivals. For instance … also segmented by process into cell isolation, sample preparation, and genomic analysis. By end user it is segmented into academic institutes, biopharmaceutical companies, and clinical research institutes. Here Is A List Of Similar Reports By …

Food and Drug Administration

FDA Grants Breakthrough Device Designation to DNAe’s Sequencing Diagnostic | Business Wire | 4/9/2020

LONDON & CARLSBAD, Calif.- DNAe, the next generation sequencing company developing novel diagnostics for use at the point-of-need, today announced that the US Food and Drug Administration (FDA) has granted it a “Breakthrough Device” designation for its pioneering platform and first assay. DNAe has reinvented sequencing in order to develop a compact device operable by non-specialist users. LiDia-SEQ™ will, for the first time, bring genomic analysis into …

CDC

DermTech Announces Response to COVID-19 | Business Wire | 3/25/2020

… an effort to limit the spread of COVID-19, we are managing our staffing and travel as guided by the CDC, OSHA, and state and local governments. We have implemented a work from home policy … leading to improved patient care and lower costs. DermTech provides genomic analysis of skin samples collected non-invasively using an adhesive patch rather than a scalpel. DermTech markets and develops products that facilitate the early …

National Institutes of Health

COVID-19 not man-made, comparative genomic study finds | Modern Healthcare | 3/18/2020

… man-made, comparative genomic study finds Modern Healthcare Print AP This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, orange … evolved from naturally occurring strains, according to a new comparative genomic analysis. “By comparing the available genome sequence data for known coronavirus strains, we can firmly determine that SARS-CoV-2 originated through natural processes …

RNA Sequencing

Genomic Testing Cooperative to Present Data on its Proprietary RNA Profiling and Artificial Intelligence Algorithms at American Society of Hematology Annual Meeting | PR Newswire | 12/3/2019

… Chief Executive Officer and Chief Medical Officer stated, “Cancer is complex disease and requires complex biomarkers for predicting its behavior. RNA Sequencing provides a wealth of information that can be used for predicting clinical course … Marrow: The Role for Complementary Peripheral Blood and Bone Marrow Genomic Analysis” Collaborators: Departments of Leukemia, Genomic, and Hematopathology, UT MD Anderson Cancer Center, Houston, TX. About Genomic Testing Cooperative, LCA Genomic Testing Cooperative (GTC …

Biotech

DNA Sequencing Market Growing Technology Opportunities and Future Business Trends to 2023 – Eurofins Scientific, Gatc Biotech, Macrogen, Oxford Nanopore | 11/27/2019

… high accuracy & speed, and precise results even from low sample input are offered by DNA sequencing over microarray and other genomic analysis methods. DNA sequencing is used to execute various applications such as biomarker discovery … Players of the DNA Sequencing Market are: Eurofins Scientific , Gatc Biotech , Macrogen, Oxford Nanopore Technologies, Bio-Rad Laboratories, DNASTAR, Biomatters , New England Biolabs, Myriad Genetics, Get sample copy of “DNA Sequencing Market” at: https://www.reportsweb.com …

Medical Research

Mary-Claire King, PhD, Joins the New York Genome Center as Senior Associate Core Member | PR Newswire | 11/25/2019

… schizophrenia, contributing to the understanding of complex disease inheritance. In 2014, Dr. King received the Lasker Special Achievement Award for Medical Research and in 2016, the United States National Medal of Science. Dr. King is … disease, and cancer. Leveraging our strengths in whole genome sequencing, genomic analysis, and development of new genomic tools, the NYGC serves as a nexus for collaboration in disease-focused genomic research for the New York …

National Cancer Institute

Mary-Claire King, PhD, Joins the New York Genome Center as Senior Associate Core Member | PR Newswire | 11/25/2019

… on numerous government panels and with private organizations, including the National Academy of Sciences, the National Institutes of Health, the National Cancer Institute, and the Robert Wood Johnson Foundation. She also has served on the … disease, and cancer. Leveraging our strengths in whole genome sequencing, genomic analysis, and development of new genomic tools, the NYGC serves as a nexus for collaboration in disease-focused genomic research for the New York …

CRISPR

EL BIRUNI: CIENCIAS MÉDICAS NEWS [https://elbiruniblogspotcom.blogspot.com.ar] ▲ DIRECTORIO DE DOCUMENTOS EDITADOS EN NOVIEMBRE de 2019 [*] ► Contenidos Copyright by Cerasale Morteo, Víctor Norberto; 2008 a 2019. SALTA / ARGENTINA. 21 de NOVIEMBRE de 2019 [45/0161] - ONCE AÑOS AGREGANDO VALOR A LA INVESTIGACIÓN MÉDICA, A LAS CIENCIAS MÉDICAS APLICADAS Y AL CONOCIMIENTO DE LOS PACIENTES Y SUS FAMILIARES | 11/21/2019

… Shipped … Sheep as Host Species for Zoonotic Babesia venator… Epidemiologic, Entomologic, and Virologic Factors … Streptococcus suis–Associated Meningitis, Bali, In… Genomic Analysis of Fluoroquinolone- and Tetracycl… Avian Influenza A Viruses among Occupationally Exp… High Prevalence … and family health history… Confidential genetic testing and electronic health… CRISPR: the movie- New gene-editing documentary sh… Model selection for metabolomics: predicting diagn… New genetic analysis improves diagnosis of intelle… Microbes and genes in …

Precision Medicine

From 1792 to 2092: Why the Future of Cigna Is All About Personalization | 10/29/2019

… precision medicine, genomic analysis, and designer babies, there’s never been a more dynamic time to work in the industry. At Salesforce, we’ve helped companies create better connections across the entire healthcare ecosystem, so we talked to Krishnan about personalization and the future of healthcare, and the opportunities and challenges that AI presents to customers and the global workforce. Q: When you think about the future of your business, what comes …

Population Health

LifeOmic Partners with AdventHealth to Power Population Health Studies in Florida | PR Newswire | 10/16/2019

… creators of the LIFE mobile apps and the Precision Health Cloud, today announced a partnership with AdventHealth to power two population health initiatives for Florida residents. LifeOmic’s Precision Health Cloud is being used in the … surveys. Once results are received, researchers are able to conduct genomic analysis in the PHC alongside integrated medical records. “Initiatives like the Lake Nona Life and WholeMe projects give Florida residents the opportunity to make …

Clinical Genomics

LifeOmic Partners with AdventHealth to Power Population Health Studies in Florida | PR Newswire | 10/16/2019

… tolerance, caffeine metabolism and sleeplessness. LifeOmic’s Precision Health Cloud provides the underlying platform for registration, informed consent and the intake and follow-up surveys. Once results are received, researchers are able to conduct genomic analysis in the PHC alongside integrated medical records. “Initiatives like the Lake Nona Life and WholeMe projects give Florida residents the opportunity to make informed decisions about their health, “ said Dr. Don Brown , CEO and founder …

Medicaid

Hereditary Cancer Testing Markets, 2019-2027 - Growing Demand for Non-invasive Methods of Detection Presents Opportunities | Globe Newswire | 10/16/2019

… screening with the patient. They support groups and other information resources and provide emotional support to the person getting the results.Genomic analysis is used to monitor, diagnose, treat, forecast, and prevent diseases, and promote good … and Drug Administration, World Health Organization (WHO), Centers for Medicare & Medicaid Services (CMS), National Institute of Cancer Prevention and Research (NICPR), National Cancer Institute, Canadian Institutes of Health Research (CIHR), Spanish Society of Medical Oncology …

Clinical Data

Genomenon’s Mastermind to be Integrated into SOPHiA Platform and Alamut Suite | PRWeb | 10/15/2019

… the Alamut Suite . The partnership puts the most up-to-date genomic research at the fingertips of clinical researchers performing genomic analysis worldwide. The SOPHiA Platform is the technology of choice for streamlined Data-Driven … helping healthcare professionals make sense of the large amount of clinical data. SOPHiA GENETICS is democratizing Data-Driven Medicine by enabling the rapid adoption of genomic and radiomic analysis worldwide, turning data into actionable insights …

Clinical Diagnostics

Promega Hosts Fight Colorectal Cancer (Fight CRC) Research Advocacy Training and Support (RATS) Program | Business Wire | 10/11/2019

… the unique opportunity to engage in lab activities with Promega scientists while learning about topics such as: molecular oncology workflow genomic analysis for cancer bioluminescence and drug discovery immunotherapy and hereditary cancer risk microsatellite instability … their particular experiences as well,” says Heather Tomlinson, Director of Clinical Diagnostics at Promega “We are especially eager to share our insight of the role inherited genetic conditions such as Lynch syndrome plays in increasing …

Point of Care Diagnostics

DermTech Announces Appointment of Kevin Sun as Chief Financial Officer – Company Announcement - FT.com | Financial Times | 9/16/2019

… Prior to DexCom , Mr. Sun held various roles of increasing responsibility at Biosite Incorporated , a NASDAQ-listed leader in rapid point of care diagnostics. Mr. Sun holds a B.S. in Business with a dual major … leading to improved patient care and lower costs. DermTech provides genomic analysis of skin samples collected non-invasively using an adhesive patch rather than a scalpel. DermTech markets and develops products that facilitate the early …

HIPAA

Leading Pharmaceutical and Healthcare Organizations Rely on Cloudera to Power Predictive Data Insights | PR Newswire | 8/20/2019

… data can be lifesaving, as healthcare data analytics is emerging as an essential tool for patient diagnoses, detecting epidemics, enabling genomic analysis, and delivering on the promise of molecular medicine. The ability to uncover insights … policies based on the Health Insurance Portability and Accountability Act (HIPAA) requirements, and demonstrate compliance. “The Cloudera Enterprise platform is the cornerstone of our next-generation analytics platform, and the outstanding partnership we have developed …

Infection Prevention

The Growing Role Of Rapid Diagnostics And Digital Health In Long-Term Care | Health IT Outcomes | 7/11/2019

… into transmission events, in an effort to improve infection control protocols and guard facilities against future outbreaks. The future of infection prevention, particularly in high-risk patient populations, lies in a combination of rapid, accurate … is the CEO of OpGen, Inc ., a pioneering informatics and genomic analysis company providing complete solutions for patient, hospital, and network-wide infection prevention and treatment …

ACA

Myriad Genetics Receives Second Insurance Reimbursement Decision for its BRACAnalysis® Diagnostic System in Japan | Globe Newswire | 6/19/2019

BRACAnalysis Is Now Indicated as a Companion Diagnostic for Lynparza® (olaparib) in Women with Ovarian Cancer June 19, 2019 07:05 ET Source: Myriad Genetics, Inc. SALT LAKE CITY, June 19, Myriad Genetic Laboratories, Inc., a … including general/emergency testing, esoteric/research testing, companion diagnostics tests, genomic analysis, and etc. For more information, please visit http://www.srl-group.co.jp/ About Myriad Genetics Myriad Genetics Inc., is a leading personalized medicine company dedicated …

ACO

The Cerrado once connected the Andes with the Atlantic Rainforest | Phys Org | 4/18/2019

… Andes and Brazil’s Atlantic Rainforest biome are separated by almost 1,000 km of drier areas with open vegetation in the Chaco, Cerrado (Brazilian savanna), and Caatinga (Brazilian semiarid) biomes. Today, these tropical forests are not … They then used DNA sequences from 71 birds and the genomic analysis of samples from other 33 specimens to evaluate the genetic structure of the population and the gene flow within the species. Lastly, they …

Patient Registry

Goldfinch Bio Announces Collaborations With Icahn School Of Medicine At Mount Sinai And Vanderbilt University Medical Center To Augment World’s Largest Genomic Registry Of Patients With Kidney Disease - TheStreet | 10/17/2017

… genomic analysis and de-identified clinical data from Mount Sinai’s BioMe BioBank and Vanderbilt’s BioVU BioBank to expand Goldfinch’s Patient Registry, generating an unparalleled collection of insights from patients with kidney disease. Goldfinch Bio is leading a new age of therapeutic discovery and development in the kidney space, and is building the world’s largest genomic registry of patients with kidney disease to inform new disease targets, pathways, and biomarkers for …

Illumina

Illumina Acquires BlueBee to Accelerate Processing, Analysis and Sharing of Next Generation Sequencing Data at Scale | Business Wire | 6/18/2020

SAN DIEGO- Illumina, Inc. (NASDAQ: ILMN) is enhancing its capabilities to analyze and interpret the data produced by its sequencing systems with the acquisition of BlueBee, a cloud-based software company that provides genomics analysis … Illumina software products provides the most scalable, efficient and extensible genomic analysis solutions for both clinical and translational research use cases. BlueBee truly brings unique capabilities, while ensuring secure deployment of clinical informatics across the …

Thermo Fisher

Key Players in The $852 Million Genomics Market At Investing in New Product Launches | PR Newswire | 4/13/2020

… DNA Electronics Ltd, Enumeral, Epic Sciences, Kellbenx Inc., Resolution Bio Science Inc., Wafergen Bio-systems Inc., Yikon Genomics Co. Ltd, Thermo Fisher Scientific Inc., CellBio, Beckman Coulter , Becton Dickinson , Bio-Rad, Carl Zeiss Microscopy, Cell … also segmented by process into cell isolation, sample preparation, and genomic analysis. By end user it is segmented into academic institutes, biopharmaceutical companies, and clinical research institutes. Here Is A List Of Similar Reports By …

Thermo Fisher Scientific

Key Players in The $852 Million Genomics Market At Investing in New Product Launches | PR Newswire | 4/13/2020

… DNA Electronics Ltd, Enumeral, Epic Sciences, Kellbenx Inc., Resolution Bio Science Inc., Wafergen Bio-systems Inc., Yikon Genomics Co. Ltd, Thermo Fisher Scientific Inc., CellBio, Beckman Coulter , Becton Dickinson , Bio-Rad, Carl Zeiss Microscopy, Cell … also segmented by process into cell isolation, sample preparation, and genomic analysis. By end user it is segmented into academic institutes, biopharmaceutical companies, and clinical research institutes. Here Is A List Of Similar Reports By …

Qiagen

Key Players in The $852 Million Genomics Market At Investing in New Product Launches | PR Newswire | 4/13/2020

… and aims to advance the field of CAR-T therapy. Some key players in the genomics market include 10X Genomics, Qiagen NV, Fluidigm Corporation, Johnson & Johnson Private Limited, Zephyrus Biosciences Inc., Illumina, Inc., Affymetrix, Angle … also segmented by process into cell isolation, sample preparation, and genomic analysis. By end user it is segmented into academic institutes, biopharmaceutical companies, and clinical research institutes. Here Is A List Of Similar Reports By …

Merck

Myriad Seeks Japanese Regulatory Approval for its BRACAnalysis® Diagnostic System in People with Advanced Pancreatic and Prostate Cancer | Globe Newswire | 3/30/2020

Merck & Co., Inc. in the United States and Canada). About SRL Since the establishment in 1970, SRL, Inc., a member of the Miraca Group, Japan-based leading healthcare group, has been providing comprehensive testing services as the largest commercial clinical laboratory in Japan. SRL carries out nearly 400,000,000 tests per year, covering a wide range of testing services including general/emergency testing, esoteric/research testing, companion diagnostics tests, genomic analysis

Quest Diagnostics

Global Oral Fluid Collection Devices Market Growth 2019-2024 | 10/28/2019

… Collection Devices Consumption CAGR by Region 2.2 Oral Fluid Collection Devices Segment by Type 2.2.1 General Analysis Collection Devices 2.2.2 Genomic Analysis Collection Devices 2.3 Oral Fluid Collection Devices Consumption by Type 2.3.1 Global Oral … Business Overview 12.6.2 Oral Fluid Collection Devices Product Offered 12.6.3 Quest Diagnostics Oral Fluid Collection Devices Sales, Revenue, Price and Gross Margin (2017-2019) 12.6.4 Main Business Overview 12.7.2 Oral Fluid Collection Devices Product Offered 12.7.3 …

Grand Rounds

Genomic approaches to cancer treatment discussed at WCM-Q event | 10/7/2019

The growing role of genomics in cancer treatment was examined at the latest Weill Cornell Medicine-Qatar (WCM-Q) Grand Rounds. Dr Susanna El Akiki, consultant clinical scientist in the diagnostic genomic division at Hamad Medical Corporation (HMC), gave a presentation that explained the difference between genetic and genomic analysis, described the technologies used to detect genomic changes, and discussed the impact of genomic reporting on therapeutic decision making. Dr …

Loxo Oncology

Illumina, Broad Institute Partner on Secondary Genomic Analysis | Zacks | 10/1/2019

Illumina, Broad Institute Partner on Secondary Genomic Analysis Zacks Equity Research You follow Analyst Blog - edit You follow Zacks Equity Research - edit What would you like to follow? Zacks Equity Research Cancel Read More Hide … company formed several alliances including a global strategic partnership with Loxo Oncology (to develop and commercialize a multi-gene panel for broad tumor profiling). Further, the company inked deals with Bristol-Myers and Thermo Fisher …

Bristol-Myers

Illumina, Broad Institute Partner on Secondary Genomic Analysis | Zacks | 10/1/2019

Illumina, Broad Institute Partner on Secondary Genomic Analysis Zacks Equity Research You follow Analyst Blog - edit You follow Zacks Equity Research - edit What would you like to follow? Zacks Equity Research Cancel Read More Hide … for broad tumor profiling). Further, the company inked deals with Bristol-Myers and Thermo Fisher Scientific in the field of next-generation sequencing. All these indicate that Illumina’s products still stand a chance to outreach …

Medtronic

Illumina, Broad Institute Partner on Secondary Genomic Analysis | Zacks | 10/1/2019

Illumina, Broad Institute Partner on Secondary Genomic Analysis Zacks Equity Research You follow Analyst Blog - edit You follow Zacks Equity Research - edit What would you like to follow? Zacks Equity Research Cancel Read More Hide … in the broader medical space are Styker ( SYK - Free Report ) , Medtronic ( MDT - Free Report ) and Amedisys ( AMED - Free Report ) , each holding a Zacks Rank 2 (Buy).You can see the complete list of today’s Zacks …

Varian

Genomenon Partners with Google to Make Genomic Data Available on Google Cloud Platform | PRWeb | 4/16/2019

… Inc. announced a partnership with Google to make the company’s genomic mutation data available on Google Cloud Platform. Genomenon’s Cited Variants Reference (CVR) data will be a public dataset available in BigQuery, Google Cloud’s big … be used as an evidence filter for clinical actionability in genomic analysis pipelines (based on the presence of evidence in the literature) and a quick way to get insight into the literature for variant curation …

HLM Venture Partners

DermTech Announces Successful Closing of Business Combination with Constellation Alpha Capital Corp. | BioSpace | 9/3/2019

… exceeding the $15 million closing cash requirement previously announced. Participating investors included experienced life sciences investors such as RTW Investments, HLM Venture Partners, Irwin and Gary Jacobs, the founding family of Qualcomm, Inc., and two … PLA), enables non-invasive and early detection of melanoma using genomic analysis. Studies to date have shown that the PLA test enhances the early detection of melanoma with a higher diagnostic performance than biopsy, the …

Iris Dorbian wrote a new post, Constellation and DermTech merge, on the site PE Hub | 8/30/2019

By Iris Dorbian Constellation Alpha Capital Corp , a blank check company and DermTech , a provider of genomic analysis of skin samples, have completed their previously announced merger. Participating investors included RTW Investments, HLM Venture Partners, Irwin and Gary Jacobs and the founding family of Qualcomm Inc . Cowen and Company LLC served as financial and capital markets adviser on the transaction. The newly combined company will be trading August 30, 2019 …

Third Rock Ventures

ArcherDX Announces the Appointment of Steven J. Kafka, Ph.D. as Executive Chairman of the Board of Directors | PR Newswire | 5/29/2019

… this expanded capacity,” said Jason Myers , co-founder and Chief Executive Officer of ArcherDX. Dr. Kafka is a Partner at Third Rock Ventures, a leading healthcare venture capital firm that invests in disruptive areas of … Jason and his team deliver best in class NGS-based genomic analysis to cancer researchers and patients around the world,” said Steve Kafka . “ArcherDX’s AMP technology is the best platform to power the democratization of …

Goldfinch Bio Announces Collaborations With Icahn School Of Medicine At Mount Sinai And Vanderbilt University Medical Center To Augment World’s Largest Genomic Registry Of Patients With Kidney Disease - TheStreet | 10/17/2017

… Vanderbilt University Medical Center to generate genomic data on over 1,500 patients with proteinuric kidney disease. The collaborations will integrate genomic analysis and de-identified clinical data from Mount Sinai’s BioMe BioBank and Vanderbilt’s BioVU … people with kidney disease. Goldfinch was launched in 2016 by Third Rock Ventures, and is headquartered in Cambridge, Mass. For more information, please visit www.goldfinchbio.com . Goldfinch Bio Contact Jennifer Williams Cook Williams Communications, Inc. jennifer …

University Hospital

Myriad Receives Reimbursement for the BRACAnalysis® Diagnostic System in Japan for Patients with Breast or Ovarian Cancer Associated with HBOC | Globe Newswire | 4/6/2020

… Nakamura, M.D., Ph.D., Professor and Chairman, Department of Surgery, Division of Breast Surgical Oncology and Director, Breast Center of Showa University Hospital in Tokyo and president of the Japanese Organization of Hereditary Breast and Ovarian … including general/emergency testing, esoteric/research testing, companion diagnostics tests, genomic analysis, and etc. , please visit https://www.srl-group.co.jp/english/ . About Myriad Genetics Myriad Genetics Inc., is a leading precision medicine company dedicated to being …

Genomic Testing Cooperative to Present Data on its Proprietary RNA Profiling and Artificial Intelligence Algorithms at American Society of Hematology Annual Meeting | PR Newswire | 12/3/2019

… Expression Profiling and Deep Learning” Collaborators: University of Texas MD Anderson Cancer Center, Houston, TX ; University of California, Irvine , CA; University Hospital Basel, Basel, Switzerland ; University of Verona , Verona , Italy ; Columbia University Medical Center, New … Marrow: The Role for Complementary Peripheral Blood and Bone Marrow Genomic Analysis” Collaborators: Departments of Leukemia, Genomic, and Hematopathology, UT MD Anderson Cancer Center, Houston, TX. About Genomic Testing Cooperative, LCA Genomic Testing Cooperative (GTC …

University Medical Center

Genomic Testing Cooperative to Present Data on its Proprietary RNA Profiling and Artificial Intelligence Algorithms at American Society of Hematology Annual Meeting | PR Newswire | 12/3/2019

… Cancer Center, Houston, TX ; University of California, Irvine , CA; University Hospital Basel, Basel, Switzerland ; University of Verona , Verona , Italy ; Columbia University Medical Center, New York, NY ; Aalborg University Hospital, Aalborg, Denmark ; Well Cornell Medical College … Marrow: The Role for Complementary Peripheral Blood and Bone Marrow Genomic Analysis” Collaborators: Departments of Leukemia, Genomic, and Hematopathology, UT MD Anderson Cancer Center, Houston, TX. About Genomic Testing Cooperative, LCA Genomic Testing Cooperative (GTC …

Goldfinch Bio Announces Collaborations With Icahn School Of Medicine At Mount Sinai And Vanderbilt University Medical Center To Augment World’s Largest Genomic Registry Of Patients With Kidney Disease - TheStreet | 10/17/2017

CAMBRIDGE, Mass. , Oct. 17, 2017 /PRNewswire/ – Goldfinch Bio, a company singularly focused on discovering and developing precision therapies to treat patients with kidney disease, today announced collaborations with the Icahn School of Medicine at Mount Sinai and Vanderbilt University Medical Center to generate genomic data on over 1,500 patients with proteinuric kidney disease. The collaborations will integrate genomic analysis and de-identified clinical data from Mount Sinai’s BioMe BioBank and …

Moffitt Cancer Center

Researchers complete largest genomic analysis of Merkel cell carcinoma patients | 8/20/2019

Merkel cell carcinoma (MCC) is a rare, aggressive skin tumor that is diagnosed in approximately 2,000 people each year in the United States. Since MCC affects so few people, it is difficult to study the genetic factors that lead to its development and how those factors correlate with response to therapy. However, Moffitt Cancer Center researchers have developed the largest descriptive genomic analysis of MCC patients to date, in collaboration …

Largest genomic analysis could help improve treatment for Merkel cell carcinoma patients | 8/20/2019

Moffitt Cancer Center researchers have developed the largest descriptive genomic analysis of MCC patients to date, in collaboration with Foundation Medicine and the Dana Farber Cancer Institute. Their analysis, published in Clinical Cancer Research, will provide important information to improve the care and treatment of MCC patients for many years to come. Researchers are beginning to learn more about how MCC develops and its associated risk factors. Many patients with …

Vanderbilt University Medical Center

Goldfinch Bio Announces Collaborations With Icahn School Of Medicine At Mount Sinai And Vanderbilt University Medical Center To Augment World’s Largest Genomic Registry Of Patients With Kidney Disease - TheStreet | 10/17/2017

CAMBRIDGE, Mass. , Oct. 17, 2017 /PRNewswire/ – Goldfinch Bio, a company singularly focused on discovering and developing precision therapies to treat patients with kidney disease, today announced collaborations with the Icahn School of Medicine at Mount Sinai and Vanderbilt University Medical Center to generate genomic data on over 1,500 patients with proteinuric kidney disease. The collaborations will integrate genomic analysis and de-identified clinical data from Mount Sinai’s BioMe BioBank and …

Goldfinch Bio Announces Collaborations with Icahn School of Medicine at Mount Sinai and Vanderbilt University Medical Center to Augment World’s Largest Genomic Registry of Patients with Kidney Disease | PR Newswire | 10/17/2017

Goldfinch Bio Announces Collaborations with Icahn School of Medicine at Mount Sinai and Vanderbilt University Medical Center to Augment World’s Largest Genomic Registry of Patients with Kidney Disease News provided by 07:30 ET Share this … 1,500 patients with proteinuric kidney disease. The collaborations will integrate genomic analysis and de-identified clinical data from Mount Sinai’s BioMe BioBank and Vanderbilt’s BioVU BioBank to expand Goldfinch’s Patient Registry, generating an unparalleled collection …

John Dobak

DermTech Announces Inclusion in the Russell 2000 Index | Business & Finance | manchestertimes.com | Business Wire | 6/30/2020

… our inclusion in the Russell 2000 ® Index, one of the most widely cited performance benchmarks for small-cap companies,” said John Dobak, M.D., Chief Executive Officer of DermTech. “This is an important milestone for DermTech … leading to improved patient care and lower costs. DermTech provides genomic analysis of skin samples collected non-invasively using an adhesive patch rather than a scalpel. DermTech markets and develops products that facilitate the early …

DermTech Announces Response to COVID-19 | Business Wire | 3/25/2020

… leader in precision dermatology enabled by a non-invasive skin genomics platform, today released the following letter from its CEO John Dobak, M.D.: We at DermTech are monitoring the COVID-19 pandemic daily. In these … leading to improved patient care and lower costs. DermTech provides genomic analysis of skin samples collected non-invasively using an adhesive patch rather than a scalpel. DermTech markets and develops products that facilitate the early …

Jason Myers

ArcherDX Enters Collaboration with Bristol Myers Squibb to Apply Personalized Cancer Monitoring (PCM™) to Clinical Research | PR Newswire | 6/18/2020

… precision oncology into early-stage cancers, when the cancer is typically easier to cure compared to late-stage cancers,” said Jason Myers , Chief Executive Officer and co-founder of ArcherDX. “This collaboration further underscores our … and outside the U.S. About ArcherDX ArcherDX is a leading genomic analysis company democratizing precision oncology through a suite of products and services that are highly accurate, personal, actionable and easy to use in local …

ArcherDX Receives Approval for Archer®MET Companion Diagnostic for TEPMETKO® (Tepotinib) in Advanced Non-Small Cell Lung Cancer in Japan | PR Newswire | 3/25/2020

… diagnostic for TEPMETKO means NSCLC patients will have access to Merck KGaA, Darmstadt, Germany’s targeted therapy with demonstrated efficacy,” said Jason Myers , Ph.D., Chief Executive Officer and co-founder, ArcherDX. “This approval is the most … use outside of Japan . About ArcherDX ArcherDX is a leading genomic analysis company democratizing precision oncology through a suite of products and services that are highly accurate, personal, actionable and easy to use in local …